Advances in Breast Cancer: Personalized Medicine
45 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is suggested to contribute to disparities in breast cancer outcomes?

  • Genomic variations in drug metabolizing enzymes (correct)
  • Increased breast cancer incidence among all races
  • Higher socioeconomic status of African American women
  • Similar treatment protocols across populations

What factor is NOT mentioned as a potential cause for disparities in breast cancer treatment outcomes?

  • Undertreatment of certain populations
  • Patient age and gender (correct)
  • Differences in tumor biology
  • Socioeconomic factors

Which group of women is noted to have a lower incidence but higher mortality from breast cancer?

  • White women
  • Women of African ancestry (correct)
  • Hispanic women
  • Asian women

What has been shown to significantly reduce the benefits of chemotherapy?

<p>Delays or reductions in treatment (C)</p> Signup and view all the answers

What percentage of patients in a retrospective study received inadequate treatment?

<p>36.5% (D)</p> Signup and view all the answers

What is the proportion of estrogen receptor–negative, basal-like subtype in indigenous Africans?

<p>27% (D)</p> Signup and view all the answers

Which population has the lowest proportion of estrogen receptor–negative, unclassified breast tumors?

<p>Japanese (A)</p> Signup and view all the answers

What percentage of HER2-positive tumors is reported across most populations?

<p>15% (B)</p> Signup and view all the answers

Why is integrative epidemiology important in drug development?

<p>It ensures drugs are effective across different populations. (D)</p> Signup and view all the answers

What factor influences the etiology and prognosis of breast cancer in different populations?

<p>Intrinsic molecular subtypes (D)</p> Signup and view all the answers

Among which racial/ethnic groups is the gradient of estrogen receptor–negative breast tumors highest?

<p>Indigenous Africans (B)</p> Signup and view all the answers

Which approach must be applied for drug development considering genomic risk factors?

<p>An integrative epidemiology approach (B)</p> Signup and view all the answers

Which population has a similar proportion of HER2-positive tumors as indigenous Africans?

<p>All populations except Japanese (A)</p> Signup and view all the answers

What was the reduction in chemotherapy effectiveness for estrogen receptor–negative tumors using cyclophosphamide/doxorubicin/5-fluorouracil?

<p>55% (A)</p> Signup and view all the answers

Which factor may enhance the effectiveness of hormonal therapies?

<p>Considering genetic variants that affect metabolism (C)</p> Signup and view all the answers

What is the role of genetic polymorphisms in drug treatment outcomes?

<p>They can affect both cancer risk and treatment response. (A)</p> Signup and view all the answers

Which gene variants are particularly mentioned as influencing cancer risk and drug metabolism?

<p>CYP3A4 and CYP191A (B)</p> Signup and view all the answers

What is a common reason for the failure of tamoxifen therapy?

<p>Intrinsic or acquired resistance of the tumor (B)</p> Signup and view all the answers

Integrative epidemiology proposes that genes implicated in what may also affect therapeutic outcomes?

<p>Cancer risk and treatment response (C)</p> Signup and view all the answers

What therapy is commonly used for preventing and treating estrogen receptor–positive breast cancer?

<p>Tamoxifen (C)</p> Signup and view all the answers

The variability in drug pharmacokinetics may be associated with which of the following?

<p>Common genetic polymorphisms (D)</p> Signup and view all the answers

What is the primary role of BRCA1 in cellular processes?

<p>Participating in DNA repair pathways (B)</p> Signup and view all the answers

Cells lacking BRCA1 or BRCA2 primarily rely on which type of DNA repair mechanisms?

<p>Error-prone nonhomologous end joining (A)</p> Signup and view all the answers

Which effect is observed in BRCA1-deficient cells?

<p>Greater frequency of nonhomologous end joining (B)</p> Signup and view all the answers

What is a consequence of impaired response to DNA damage in BRCA1-deficient cells?

<p>Increased genomic instability (A)</p> Signup and view all the answers

BRCA2 is known to be equivalent to which protein in the context of Fanconi anemia?

<p>FANCD1 (A)</p> Signup and view all the answers

Which of the following proteins interact with FANCL as part of the nuclear response to DNA damage?

<p>BRCA1, RAD51, and FANCD2 (B)</p> Signup and view all the answers

What is the function of ubiquitinilated FANCD2 in relation to BRCA1?

<p>To localize with BRCA1 and RAD51 in DNA repair foci (B)</p> Signup and view all the answers

The disruption of the FA-BRCA pathway results in which of the following?

<p>Impaired DNA damage response and higher cancer risk (C)</p> Signup and view all the answers

What percentage of breast cancer cases is estimated to arise from inherited mutations in breast cancer susceptibility genes?

<p>5% to 10% (C)</p> Signup and view all the answers

Which gene is known for its significant role in breast cancer susceptibility?

<p>BRCA1 (B)</p> Signup and view all the answers

What has facilitated the development of targeted therapies in breast cancer?

<p>Identification of molecular mechanisms (B)</p> Signup and view all the answers

Which targeted therapy is associated with the estrogen receptor in breast cancer treatment?

<p>Tamoxifen (A)</p> Signup and view all the answers

What is the role of HER2 in breast cancer?

<p>It is a major predictor of treatment response. (C)</p> Signup and view all the answers

What advancement in technology has been pivotal for biological characterization in breast cancer?

<p>DNA microarray technology (C)</p> Signup and view all the answers

Which type of alteration is central to early detection and treatment of breast cancer?

<p>Genetic alterations (A)</p> Signup and view all the answers

Which treatment is a humanized monoclonal antibody used in HER2-positive breast cancer?

<p>Trastuzumab (A)</p> Signup and view all the answers

What characteristics define luminal A subtypes in breast cancer?

<p>HER2 negative, estrogen receptor positive, and/or progesterone receptor positive (A)</p> Signup and view all the answers

Which subtype is characterized by being estrogen receptor negative, progesterone receptor negative, and HER2 positive?

<p>HER2-like (B)</p> Signup and view all the answers

What is the primary use of the Oncotype Dx assay in breast cancer treatment?

<p>To identify patients who will benefit from chemotherapy in addition to antiestrogen therapy (A)</p> Signup and view all the answers

What distinguishes the MammaPrint assay from other biomarker tests?

<p>It differentiates between tumors based on 70-gene signatures regardless of estrogen receptor status. (B)</p> Signup and view all the answers

Which subtype of breast cancer is considered unclassified?

<p>Estrogen receptor negative for all five markers (D)</p> Signup and view all the answers

What is the Food and Drug Administration's involvement with Oncotype Dx and MammaPrint?

<p>Both assays are FDA-approved and are undergoing prospective validation. (A)</p> Signup and view all the answers

Which of the following is NOT a characteristic of basal-like breast cancer?

<p>HER2 positive (B)</p> Signup and view all the answers

What critical role do biomarkers play in the context of breast cancer treatment?

<p>To enable the selection of optimal treatment based on individual tumor characteristics (A)</p> Signup and view all the answers

Flashcards

Genetic alterations in breast cancer

Genetic alterations play a crucial role in early breast cancer detection, diagnosis, and treatment.

BRCA1 and BRCA2 genes

Genes like BRCA1 and BRCA2 are highly linked to an increased risk of breast cancer when inherited.

Genetic risk factors in breast cancer

While we understand some genes contribute to breast cancer risk, many other genetic factors involved in BRCA1 and BRCA2 mutation carriers are still being discovered.

DNA microarray technology in breast cancer

DNA microarray technology helps us understand the biological characteristics and treatment plans for breast cancer by examining gene expression profiles.

Signup and view all the flashcards

Molecular biology and gene expression signatures in breast cancer

Understanding the molecular basis and gene expression patterns of breast cancer is vital for developing new prevention and treatment strategies.

Signup and view all the flashcards

Targeted therapies in breast cancer

Targeted therapies, like those targeting the estrogen receptor and HER2 oncogene, are effective based on understanding the specific biological mechanisms involved.

Signup and view all the flashcards

Estrogen receptor in breast cancer

Understanding the estrogen receptor's role in premenopausal women with hormone-sensitive breast cancer led to targeted therapies for this specific type of cancer.

Signup and view all the flashcards

HER2 oncogene and trastuzumab

Amplification of the HER2 oncogene is a key indicator for predicting the effectiveness of treatments like trastuzumab, a monoclonal antibody against HER2.

Signup and view all the flashcards

Breast Cancer Subtypes and Ethnicity

The proportion of estrogen receptor-negative tumors in breast cancer varies significantly across different populations, with African populations having the highest prevalence.

Signup and view all the flashcards

Estrogen Receptor-Negative Breast Cancer

A specific type of breast cancer that does not respond to estrogen-blocking treatments.

Signup and view all the flashcards

HER2-Positive Breast Cancer

A specific type of breast cancer that is driven by the growth factor HER2.

Signup and view all the flashcards

Population Epidemiology

The study of how different populations are affected by diseases and factors influencing their health.

Signup and view all the flashcards

Integrative Epidemiology in Drug Development

The process of developing a drug that takes into consideration the specific needs and genetics of different ethnic groups.

Signup and view all the flashcards

Importance of Diverse Clinical Trial Participants

Clinical trials for breast cancer drugs should be conducted in populations that will use the drugs to ensure effectiveness and safety.

Signup and view all the flashcards

Ethnic Variations in Breast Cancer Subtypes

Ethnic groups have different rates of various breast cancer subtypes, highlighting the importance of considering ethnicity in diagnosis and treatment.

Signup and view all the flashcards

Personalized Breast Cancer Treatment

An approach to breast cancer treatment that considers the specific subtype of cancer present in each patient.

Signup and view all the flashcards

Luminal A Breast Cancer

A type of breast cancer characterized by estrogen receptor positivity, progesterone receptor positivity, and HER2 negativity.

Signup and view all the flashcards

Luminal B Breast Cancer

A type of breast cancer characterized by estrogen receptor positivity and/or progesterone receptor positivity, but also HER2 positivity.

Signup and view all the flashcards

HER2-like Breast Cancer

A type of breast cancer with negative estrogen and progesterone receptors, but positive HER2.

Signup and view all the flashcards

Basal-like Breast Cancer

A type of breast cancer characterized by negative estrogen and progesterone receptors, negative HER2, but positive markers like cytokeratin 5/6 and/or epidermal growth factor receptor.

Signup and view all the flashcards

Unclassified Breast Cancer

A type of breast cancer that doesn't fit into the other categories based on its marker expression.

Signup and view all the flashcards

Multigene Expression Profile

A lab test that analyzes specific genes in a tumor to predict how likely a cancer is to spread and how well a patient will respond to certain treatments.

Signup and view all the flashcards

Oncotype Dx

A type of multigene expression profile that analyzes 21 genes to predict the effectiveness of chemotherapy in patients with node-negative, estrogen receptor-positive breast cancer.

Signup and view all the flashcards

MammaPrint

A type of multigene expression profile that uses a 70-gene signature to predict the risk of relapse in patients with node-negative breast cancer.

Signup and view all the flashcards

What is BRCA1's function?

BRCA1 is a protein that plays a crucial role in DNA repair, specifically in the homology-directed recombination (HDR) pathway.

Signup and view all the flashcards

How does BRCA1 participate in DNA repair?

BRCA1 works within protein complexes that help cells detect DNA damage, signal the need for repair, and then repair the damage using HDR.

Signup and view all the flashcards

What happens to cells lacking BRCA1?

Cells without functional BRCA1 cannot properly sense or repair DNA damage. This leads to genomic instability, which means the DNA is prone to mutations.

Signup and view all the flashcards

What DNA repair pathway does BRCA1 rely on?

BRCA1 is essential for the HDR pathway, a precise mechanism for repairing DNA breaks.

Signup and view all the flashcards

What happens without BRCA1's HDR pathway?

Cells lacking BRCA1 often switch to less accurate repair mechanisms, such as nonhomologous end joining (NHEJ) and single-strand annealing, increasing the risk of mutations.

Signup and view all the flashcards

Why is BRCA1 deficiency linked to cancer?

BRCA1 deficiency leads to an increased risk of cancer because the DNA is prone to mutations that drive uncontrolled cell growth.

Signup and view all the flashcards

What pathway is linked to BRCA1 and BRCA2?

The Fanconi anemia pathway, responsible for DNA repair, involves BRCA1 and BRCA2.

Signup and view all the flashcards

How does the Fanconi anemia pathway affect cancer risk?

Disruptions in the Fanconi anemia pathway, which include BRCA1 and BRCA2, lead to increased sensitivity to DNA damage and a higher risk of cancer.

Signup and view all the flashcards

Drug Metabolism and Transport Variations

Differences in how individuals process drugs, based on their genetic makeup, can affect treatment outcomes, especially in diverse populations.

Signup and view all the flashcards

Racial Disparities in Breast Cancer Outcomes

African American women experience a higher mortality rate from breast cancer despite a lower incidence rate compared to white women.

Signup and view all the flashcards

Under-treatment in Breast Cancer

Under-treatment, or receiving less than the standard treatment, is prevalent among African American women with breast cancer.

Signup and view all the flashcards

Beyond Socioeconomic Factors

Socioeconomic factors and tumor biology alone cannot fully explain the disparity in breast cancer outcomes between racial groups.

Signup and view all the flashcards

Chemotherapy Dose Impacts

Large clinical trials have shown that delays, reductions, or early termination of chemotherapy significantly decrease treatment benefits.

Signup and view all the flashcards

Pharmacokinetics

The effect of a drug on an individual's body, including how it is absorbed, processed, and eliminated.

Signup and view all the flashcards

Pharmacogenetics

The study of how genetic variations impact a drug's effectiveness and side effects.

Signup and view all the flashcards

Pharmacogenetic Variations

Genetic variations in drug-metabolizing enzymes and transporters can affect drug metabolism.

Signup and view all the flashcards

Integrative Epidemiology

A field that combines epidemiology, genetics, and environmental factors to explore the interplay of genes, environment, and disease.

Signup and view all the flashcards

Cancer Risk and Treatment Response

Genes implicated in cancer risk can also influence a person's response to cancer treatments.

Signup and view all the flashcards

Glutathione-related Transporters and CYP Enzymes

These genes, among others, have been linked to both cancer risk and the processing of chemotherapy drugs.

Signup and view all the flashcards

Tamoxifen

A drug that blocks the estrogen receptor, used to prevent and treat breast cancer.

Signup and view all the flashcards

Tamoxifen Resistance

The resistance of cancer cells to the effects of Tamoxifen.

Signup and view all the flashcards

Study Notes

Advances in Breast Cancer: Pathways to Personalized Medicine

  • Breast cancer is a complex disease driven by progressive gene mutations and epigenetic dysregulation of pathways.
  • Inter-individual variability exists in disease diagnosis and phenotypic expression.
  • Globally, an estimated 1,152,161 new cases are diagnosed annually.
  • Cancer control strategies should focus on population and individual levels to reduce morbidity and mortality.
  • BRCA1 and BRCA2 gene mutations significantly increase the risk of breast and ovarian cancers. This has revolutionized our understanding of genetic breast cancer.
  • Enhanced understanding of tumor host biology has led to improved multidisciplinary breast cancer management.
  • Genomic biomarkers are increasingly utilized clinically.
  • Pharmacogenomic end points are becoming more common in clinical trial design, especially for breast cancer.
  • Targeted therapies are valuable when combined with prognostic information, but these are less prevalent for triple-negative breast cancer.
  • The past decade has seen substantial advancements in our understanding of the molecular mechanisms driving breast cancer progression.
  • Genetic alterations are crucial for early detection, diagnosis, and treatment.
  • Mutations in breast cancer susceptibility genes, like BRCA1 and BRCA2, contribute to 5-10% of breast cancer cases.
  • Genetic variations influence breast cancer progression and characteristics.
  • Common low-penetrance variants, identified through genome-wide association studies, play a role in breast cancer development, particularly in those of European ancestry.

High-Penetrance Genes

  • Preventive measures are beneficial for those with identified high-penetrance BRCA1/2 mutations.
  • Mutations in other genes (TP53 in Li-Fraumeni syndrome and PTEN in Cowden syndrome) contribute to a smaller fraction of hereditary breast cancer.
  • Mutation prevalence varies by ethnic background, with Ashkenazi Jewish populations and Icelanders being examples.
  • Understanding prevalence and penetrance rates is vital for individual risk assessment.

Genomic Approach to Primary Prevention of Breast Cancer

  • BRCA1/2 mutation carriers have a high risk of breast and ovarian cancers.
  • Genetic counseling and testing have become standard for high-risk individuals.
  • Risk prediction models are available to estimate risk in individuals with family history or mutations.
  • Specific genomic discoveries are reforming traditional approaches to breast cancer management.

High-Penetrance Genes

  • Preventive measures for those with identified high-penetrance genes (BRCA1/2) have demonstrable benefits.
  • Studies show that mutation prevalence varies significantly across ethnic groups.
  • Early detection and personalized assessment are critical in high-risk populations.

A Genomic Approach to Treatment of Breast Cancer

  • Understanding specific molecular subtypes of breast cancer is vital for tailored treatment.
  • Triple-negative breast cancers pose considerable challenges for oncologists.
  • Genetic testing has identified a correlation between specific genomic subtypes and treatment.

Integrative Epidemiology

  • Pharmacogenomic variations influence drug efficacy and toxicity.
  • Personalized dosing approaches for cancer therapies are emerging, considering individual genotypes.
  • Understanding inter-individual and interethnic variability in drug metabolism and transport is critical.
  • Personalized risk assessment tools may improve treatment outcomes in diverse populations.

The Epigenome and Breast Cancer

  • Epigenetic changes, alterations in gene expression without DNA sequence variations, play a role in breast cancer progression.
  • DNA methylation is a key epigenetic modification implicated in abnormal gene expression in cancer, especially related to tumor suppressor gene expression.
  • Specific epigenetic changes may serve as prognostic and/or predictive indicators for cancer development.

Functional Equivalence Between Epigenetic Silencing and Genetic Suppression

  • Epigenetic silencing of BRCA1 in sporadic cancers has possible implications for clinical practice. Decreased BRCA1 expression can lead to increased sensitivity to DNA-damaging agents.
  • Defective DNA repair can lead to genomic instability and increased cancer susceptibility.

Genomic Approach to Drug Development

  • Pharmacogenomics helps personalize drug treatment.
  • Genetic variations influence how patients metabolize drugs.
  • Tailored drug dosages aim to optimize efficacy and reduce adverse effects.
  • Genotyping can help identify patients who are unlikely to respond to a particular drug.

Molecular Subtypes and Clinical Practice

  • Breast cancer subtypes, like estrogen receptor-positive, HER2-positive, triple-negative, exhibit variable distribution across populations.
  • Differences in subtype proportions influence how cancer develops and progresses across ethnic groups.

Conclusion and Future Directions

  • Targeted therapies and predictive markers are improving breast cancer treatment.
  • More knowledge is needed to better treat triple-negative breast cancer.
  • Novel therapies including microRNAs and other biomarkers are showing promise.
  • Improvements in detection and prevention, as well as treatment of breast cancer, may better serve patients with different ancestry.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Related Documents

Advances in Breast Cancer: Pathways to Personalized Medicine PDF

Description

Explore the latest advancements in breast cancer research and treatment, focusing on personalized medicine strategies. This quiz highlights the genetic factors, epidemiology, and management approaches that are shaping the future of breast cancer care. Test your knowledge on how genomics and pharmacogenomics are revolutionizing treatment plans.

More Like This

Understanding Cancer Genetics Quiz
9 questions

Understanding Cancer Genetics Quiz

HonestSynergy avatar
HonestSynergy
Breast Cancer Risk Factors
15 questions

Breast Cancer Risk Factors

MomentousButtercup avatar
MomentousButtercup
Oncology Study Notes: Breast and Lung Cancer
12 questions

Oncology Study Notes: Breast and Lung Cancer

JudiciousSun avatar
JudiciousSun
Use Quizgecko on...
Browser
Open
Browser
Browser